Hematology

Malignancy

Questions discussed in this category

What is your approach to screening for malignancy in dermatomyositis patients who do not have a high risk antibody profile and whose disease responds well to treatment?

Do you pursue screening beyond age-appropriate malignancy screening, especially in younger patients? For how long do you continue to monitor beyond th...

1 Answer available

Does discovery of clonal hematopoiesis on liquid biopsy for solid tumors change your treatment approach in terms of which chemotherapy to offer for the solid tumor?

1 Answer available

Papers discussed in this category

Nature reviews. Rheumatology, 2023 Nov 09

International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative.

Hematology

Malignancy

Questions discussed in this category

Papers discussed in this category

Related Topics in Hematology